Despite tumor heterogeneity, the influences from unique immune components, HPV states, and protein data were not available in this approach, and the transcription investigation in this study identified the concordant disruption of the B7/CD28 checkpoint ligand–receptor interaction in HNSCC or OSCC tumors. The gene discussed is CD28; the disease is head and neck squamous cell carcinoma.